The GOP is renewing its focus on the abortion pill
Three Republican-led states are taking another crack at suing the FDA over the abortion pill, mifepristone


Since the end of Roe. v. Wade, the abortion drug mifepristone has increasingly become a flashpoint between pro-life and pro-choice advocates. Four months after the Supreme Court rejected a lawsuit to reverse changes by the Food and Drug Administration that made the drug more widely accessible, a group of conservative states is taking another crack at bringing the issue back to court.
Abortion pills are back on the chopping block
The attorneys general of three GOP-led states — Missouri, Idaho, and Kansas — have banded together to revive and file a new lawsuit against the FDA. The suit hopes to reverse several regulatory changes the agency has made since 2016 that greatly expanded access to mifepristone. The states claim they have standing to sue because the FDA's actions violate state abortion laws by "enabling an out-of-state abortion drug distribution network." In addition to some of the points revived from the first case, the new lawsuit seeks to outlaw giving the medication to anyone under 18. It also wants to tamp down on the "fast-growing practice of prescribing abortion pills through telemedicine and mailing them to patients," including to states with abortion bans, said The New York Times.
The original lawsuit, which was filed in 2022 by anti-abortion doctors and groups, was unanimously rejected by the Supreme Court. The plaintiffs had no standing to sue the FDA because they "do not prescribe or use mifepristone" themselves and were instead trying to regulate the actions of others, Justice Brett Kavanaugh said in the court's opinion in the case. Last year, Missouri, Idaho, and Kansas petitioned to join the suit at the lower court level and were granted the status of intervenors. After the court dismissed the original case, they filed an amended complaint as plaintiffs.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The attorneys general also argued that mailing abortion pills violates the Comstock Act, a "19th-century law that's laid dormant for decades that bans the mailing of anything related to abortion," said Forbes. If they successfully convince the court, the ruling could "help anti-abortion rights advocates use that law to ban abortion more broadly." The act bans not just mailing the pills but any equipment related to abortion. It has been viewed as a "potential way for Republicans to functionally outlaw abortion without imposing a federal ban," as it would make it "largely impossible to perform the procedure."
'A nakedly political and judge-shopping ploy'
The states might have a slight edge over the original plaintiffs regarding having the standing to take on the FDA. Still, their ability to claim the FDA is harming them could face substantial challenges, David S. Cohen, a law professor at Drexel University, said to the Times. It is also questionable that the states filed in the same court where the original group was rejected. "It is a nakedly political and judge-shopping ploy," Cohen said. If Missouri, Idaho, and Kansas are "really are harmed by these pills," they should file in their states. But they want to appear before U.S. District Judge Matthew Kacsmaryk, a Trump appointee, so they can "piggyback on this lawsuit that had no standing in the first place, and that shouldn't be allowed."
It is ironic that the states' invocation of the Comstock Act "represents a deliberate effort to upend their sovereign authority over abortion," Shoshanna Ehrlich said at Ms. Magazine. In doing so, they are "calling upon the power of federal law to cut off access to medication abortion in states where abortion is legal — thus upending their sovereign authority." The right's "relentless post-Dobbs crusade" to block access to abortion "represents a power grab by states aimed at forcing pregnant people, including teens, to bear children by legal fiat."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
A running list of RFK Jr.'s controversies
In Depth The man atop the Department of Health and Human Services has had no shortage of scandals over the years
By Brigid Kennedy
-
Film reviews: Sinners and The King of Kings
Feature Vampires lay siege to a Mississippi juke joint and an animated retelling of Jesus' life
By The Week US
-
Music reviews: Bon Iver, Valerie June, and The Waterboys
Feature "Sable, Fable," "Owls, Omens, and Oracles," "Life, Death, and Dennis Hopper"
By The Week US
-
'"Andor" examines all sides of how empires operate'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US
-
Trump tariffs place trucking industry in the crosshairs
IN THE SPOTLIGHT As the White House barrels ahead with its massive tariff project, American truckers are feeling the heat from a global trade war
By Rafi Schwartz, The Week US
-
El Salvador's CECOT prison becomes Washington's go-to destination
IN THE SPOTLIGHT Republicans and Democrats alike are clamoring for access to the Trump administration's extrajudicial deportation camp — for very different reasons
By Rafi Schwartz, The Week US
-
Supreme Court takes up Trump birthright appeal
Speed Read The New Jersey Attorney General said a constitutional right like birthright citizenship 'cannot be turned on or off at the whims of a single man'
By Rafi Schwartz, The Week US
-
'This is not an unusual story'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US
-
Why the GOP is nervous about Ken Paxton's Senate run
Today's Big Question A MAGA-establishment battle with John Cornyn will be costly
By Joel Mathis, The Week US
-
13 potential 2028 presidential candidates for both major parties
In Depth A rare open primary for both parties has a large number of people considering a run for president
By David Faris
-
'You shouldn't need a private company to fill out paperwork for you'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US